These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30430397)

  • 1. Molecular mechanisms of apoptosis and autophagy elicited by combined treatment with oridonin and cetuximab in laryngeal squamous cell carcinoma.
    Cao S; Huang Y; Zhang Q; Lu F; Donkor PO; Zhu Y; Qiu F; Kang N
    Apoptosis; 2019 Feb; 24(1-2):33-45. PubMed ID: 30430397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway.
    Cao S; Xia M; Mao Y; Zhang Q; Donkor PO; Qiu F; Kang N
    Int J Oncol; 2016 Nov; 49(5):2075-2087. PubMed ID: 27667173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab enhances oridonin-induced apoptosis through mitochondrial pathway and endoplasmic reticulum stress in laryngeal squamous cell carcinoma cells.
    Kang N; Cao S; Jiang B; Zhang Q; Donkor PO; Zhu Y; Qiu F; Gao X
    Toxicol In Vitro; 2020 Sep; 67():104885. PubMed ID: 32407876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
    Kang N; Zhang JH; Qiu F; Tashiro S; Onodera S; Ikejima T
    Cancer Lett; 2010 Aug; 294(2):147-58. PubMed ID: 20202741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
    Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
    Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells.
    Yang H; Wang J; Khan S; Zhang Y; Zhu K; Zhou E; Gong M; Liu B; Kan Q; Zhang Q
    Anticancer Drugs; 2022 Jan; 33(1):e444-e452. PubMed ID: 34520434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
    Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
    Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma.
    Xu ZZ; Fu WB; Jin Z; Guo P; Wang WF; Li JM
    Leuk Lymphoma; 2016; 57(4):888-98. PubMed ID: 26415087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer.
    Lu W; Liu L; Kang X; Ren K; Huang Y; Cheng M; Li X; Xu F; Xu X
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(7):1022-1033. PubMed ID: 38818581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of PERK/eIF2α/CHOP pathway enhances oridonin-induced apoptosis by inhibiting autophagy in Small-Cell lung cancer cells.
    Xu L; Jiang Y; Bi Y; Zheng S; Wu Y; Wu Y; Xu Y; Chen J
    Biomed Pharmacother; 2024 Jun; 175():116684. PubMed ID: 38713951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
    Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
    Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy.
    Zhang LD; Liu Z; Liu H; Ran DM; Guo JH; Jiang B; Wu YL; Gao FH
    Int J Oncol; 2016 Aug; 49(2):657-65. PubMed ID: 27278249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl radical (·OH) played a pivotal role in oridonin-induced apoptosis and autophagy in human epidermoid carcinoma A431 cells.
    Yu Y; Fan SM; Song JK; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2012; 35(12):2148-59. PubMed ID: 23207767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of mTOR and EGFR targeting in an orthotopic xenograft model of head and neck cancer.
    Bozec A; Ebran N; Radosevic-Robin N; Sudaka A; Monteverde M; Toussan N; Etienne-Grimaldi MC; Nigro CL; Merlano M; Penault-Llorca F; Milano G
    Laryngoscope; 2016 Apr; 126(4):E156-63. PubMed ID: 26597440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apigenin enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling.
    Hu WJ; Liu J; Zhong LK; Wang J
    Biomed Pharmacother; 2018 Jun; 102():681-688. PubMed ID: 29604587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oridonin enhances the cytotoxicity of 5-FU in renal carcinoma cells by inducting necroptotic death.
    Zheng W; Zhou CY; Zhu XQ; Wang XJ; Li ZY; Chen XC; Chen F; Che XY; Xie X
    Biomed Pharmacother; 2018 Oct; 106():175-182. PubMed ID: 29958141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab enhances cisplatin-induced endoplasmic reticulum stress-associated apoptosis in laryngeal squamous cell carcinoma cells by inhibiting expression of TXNDC5.
    Peng F; Zhang H; Du Y; Tan P
    Mol Med Rep; 2018 Mar; 17(3):4767-4776. PubMed ID: 29328423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.